| 2025/0114,317 | Use of L-cysteine for improving the structure and function of gastric mucosa | Dec 27, 22 | Apr 10, 25 | Not available |
| 2025/0115,653 | FUSION PROTEIN OF INTERLEUKIN 2 AND APPLICATION THEREOF IN IBD | Jul 15, 22 | Apr 10, 25 | Not available |
| 2025/0109,144 | THERAPEUTIC AGENTS FOR ENHANCING EPITHELIAL AND/OR ENDOTHELIAL BARRIER FUNCTION | Dec 13, 24 | Apr 03, 25 | Not available |
| 2025/0101,063 | POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS | Jan 19, 23 | Mar 27, 25 | Not available |
| 2025/0090,604 | STRAIN OF PEDIOCOCCUS ACIDILACTICI WITH FUNCTION OF TREATING ULCERATIVE COLITIS AND APPLICATION THEREOF | Dec 01, 24 | Mar 20, 25 | Not available |
| 2025/0082,713 | Active ingredient groups and their key target combinations for the treatment of UC | Sep 07, 23 | Mar 13, 25 | Not available |
| 2025/0064,761 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | Apr 09, 24 | Feb 27, 25 | PHARMACYL AB |
| 2025/0064,769 | HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID, REDUCES FECAL CALPROTECTIN LEVELS AND PREVENTS CLINICAL RELAPSE IN ULCERATIVE COLITIS PATIENTS | Nov 12, 24 | Feb 27, 25 | Not available |
| 2025/0064,907 | THERAPEUTIC VACCINES FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | Aug 23, 24 | Feb 27, 25 | Not available |
| 2025/0049,834 | Methods and Compositions for Treating Mucositis | Sep 05, 24 | Feb 13, 25 | Not available |
| 2025/0051,286 | SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF | Dec 16, 22 | Feb 13, 25 | ORIXA THERAPEUTICS LLC |
| 2025/0051,376 | BENZIMIDAZOLE DERIVATIVE COMPOUNDS AND USE THEREOF | Dec 07, 22 | Feb 13, 25 | Not available |
| 2025/0041,359 | USE OF BIFIDOBACTERIUM LACTIS BL-99 IN PREVENTION AND/OR AMELIORATION OF GASTRITIS | Nov 30, 22 | Feb 06, 25 | Not available |
| 2025/0032,471 | Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Oct 10, 24 | Jan 30, 25 | Not available |
| 2025/0032,554 | Medicine for Preventing or Treating Enteritis and Intestinal Cancer | Oct 28, 22 | Jan 30, 25 | Not available |
| 2025/0032,568 | TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL CHINESE MEDICINE DECOCTION FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE (GERD), AND PREPARATION METHOD AND USE THEREOF | Aug 29, 24 | Jan 30, 25 | Not available |
| 2025/0034,243 | METHODS OF TREATING ULCERATIVE COLITIS | Oct 16, 24 | Jan 30, 25 | Not available |
| 2025/0018,000 | METHOD FOR TREATING AND PREVENTING ULCERATIVE COLITIS AND METHOD FOR DAI REDUCTION | Sep 30, 24 | Jan 16, 25 | BEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD; GUANGXI WEHAND-BIO PHARMACEUTICAL CO., LTD; |
| 2025/0018,057 | METHODS OF TREATMENT OF HLA-B27 RELATED INFLAMMATORY DISEASES AND COMPOSITIONS RELATED TO SAME | May 07, 24 | Jan 16, 25 | Not available |
| 2025/0019,353 | BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS | Jul 02, 24 | Jan 16, 25 | Not available |